Back To Schedule
Wednesday, June 21 • 4:00pm - 5:15pm
#377: Increasing Participation in Clinical Trials Among Under-Represented Populations

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-17-548-L04-P; CME 1.25; IACET 1.25; RN 1.25

Increasing diversity in clinical trial participation has been and remains a goal of those involved in developing medicines, including pharmaceutical industry organizations, investigative sites and regulators. Several high profile campaigns have failed to move the needle, while smaller scale initiatives are showing promise. This session would mention regulatory guidance, but would focus more on the "how" of gaining clinical trial participants from diverse backgrounds, including age, gender, race/ethnicity and geography. Sessions under this topic may include initiatives based on ethnic/racial diversity, age, gender, geography and other characteristics of special populations. Beyond regulatory mandates, key elements of successful efforts include focusing on the 1:1 conversation between patients and physicians, resources related to improving access to care (financial, geographic, insurance), referral arrangements between practicing physicians and investigators, establishing broad community-based networks around research institutions. Additional aspects to cover include inclusive clinical trial design and data generation with diverse populations.

Learning Objectives

Discuss strategies to engage and retain patients in under-represented populations; Describe challenges of including under-represented patients in novel clinical trial designs and data generation.


Mary Stober Murray, MBA


Young Adults Matter in Cancer Clinical Research
Mary Stober Murray, MBA

Needle in a Haystack: Using Digital Recruitment to Reach your Target Population
Emily Cortez

Diversity Is Not a “Trending Topic”
Kim Ribeiro, MS, MT

The Inclusive Clinical Trial: Involving Diverse Populations in Clinical Trial Design
Kelly Franchetti, BSN, RN

avatar for Mary Murray

Mary Murray

Associate Director, Diversity and Patient Engagement, Bristol-Myers Squibb Company
As an Associate Director for Diversity and Patient Engagement at Bristol-Myers Squibb, Mary facilitates collaborations with disease-specific and community-based organizations to bring relevant clinical trial options to patients and representative populations. Mary has co-chaired the... Read More →

avatar for Emily Cortez

Emily Cortez

Vice President, Program Director, TBWA/WorldHealth
Emily started her clinical research career at a clinical trial site where she coordinated patient recruitment efforts as well as interacted with patients, coordinators, sponsors, and CROs. With over 15 years in the industry, she has been involved in many facets of enrollment, including... Read More →
avatar for Kelly Franchetti

Kelly Franchetti

Vice President, Global Patient Insights and Engagement, Patient Centered Science, Mapi Group, An ICON plc Company
Kelly Franchetti, RN, CCRN, CEN, is the VP of Global Patients Insights and Engagement at Mapi/ICON. Kelly has nearly two decades of direct patient experience, gained in both hospital and industry settings including CROs, healthcare technology, patient research, and hands-on patient... Read More →
avatar for Kim Ribeiro

Kim Ribeiro

Head, Diversity and Patient Inclusion, AbbVie, Inc., United States
Kim Ribeiro, MLS (ASCP) CM, MS, has over 10 years of clinical trial patient experience with her most recent position being at AbbVie. She has a strong focus on strategy development for patient engagement, recruitment and retention planning as well as digital outreach and raising clinical... Read More →

Wednesday June 21, 2017 4:00pm - 5:15pm CDT
S505ab McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616
  07: SpecialPops, Session